Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 2/20 | 0.44 |
| ▸ | MAOB | P27338 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MIF | P14174 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12116989 | 0.95 | MAOB (0.43) | ARMAOBMAOA | |
| SCHEMBL8448295 | 0.86 | MAOB (0.51) | ARMAOBMAOAKDM4EAPP | |
| SCHEMBL4263710 | 0.86 | MAOB (0.51) | ARMAOBMAOAKDM4EAPP | |
| SCHEMBL10469532 | 0.83 | MAOB (0.40) | ARMAOBMAOA | |
| SCHEMBL19314866 | 0.82 | AR (0.44) | ARMAOBMAOAKDM4ERECQL | |
| SCHEMBL13784763 | 0.81 | LTA4H (0.50) | ARMAOBMAOAKDM4E | |
| SCHEMBL2135694 | 0.78 | MRGPRX4 (0.48) | ARMAOBMAOAKDM4ETDP1 | |
| SCHEMBL4252680 | 0.78 | GLA (0.49) | ARMAOBMAOAKDM4EMAPK1 | |
| SCHEMBL3297253 | 0.78 | NR5A1 (0.58) | KDM4E | |
| SCHEMBL11963154 | 0.77 | CYP11B1 (0.47) | AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250197388-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE | EMPRESS THERAPEUTICS, INC. | 2025-06-19 | — | — | US | disclosed |
| CN-119487012-A | Compounds, pharmaceutical compositions and methods for treating inflammatory bowel disease | 旗舰创业创新六公司 | 2025-02-18 | — | — | CN | disclosed |
| EP-4499618-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE | Flagship Pioneering Innovations VI, LLC (US) | 2025-02-05 | — | — | EP | disclosed |
| WO-2023192388-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2023-10-05 | — | — | WO | disclosed |
| US-20150259306-A1 | DESAZADESFERROTHIOCIN ANALOGUES AS METAL CHELATION AGENTS | FERROKIN BIOSCIENCES INC (US) | 2015-09-17 | — | — | US | disclosed |
| US-20150259306-A1 | DESAZADESFERROTHIOCIN ANALOGUES AS METAL CHELATION AGENTS | FERROKIN BIOSCIENCES INC (US) | 2015-09-17 | — | — | US | disclosed |
| US-20150259306-A1 | DESAZADESFERROTHIOCIN ANALOGUES AS METAL CHELATION AGENTS | FERROKIN BIOSCIENCES INC (US) | 2015-09-17 | — | — | US | disclosed |
| US-9045440-B2 | Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents | FERROKIN BIOSCIENCES, INC. (US) | 2015-06-02 | — | — | US | disclosed |
| US-9045440-B2 | Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents | FERROKIN BIOSCIENCES, INC. (US) | 2015-06-02 | — | — | US | disclosed |
| US-9045440-B2 | Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents | FERROKIN BIOSCIENCES, INC. (US) | 2015-06-02 | — | — | US | disclosed |
| EP-2566854-A2 | DESAZADESFERROTHIOCIN AND DESAZADESFERROTHIOCIN POLYETHER ANALOGUES AS METAL CHELATION AGENTS | Shire LLC (US) | 2013-03-13 | — | — | EP | disclosed |
| US-20130053387-A1 | DESAZADESFERROTHIOCIN AND DESAZADESFERROTHIOCIN POLYETHER ANALOGUES AS METAL CHELATION AGENTS | FerroKin BioScience, Inc. (US) | 2013-02-28 | — | — | US | disclosed |
| US-20130053387-A1 | DESAZADESFERROTHIOCIN AND DESAZADESFERROTHIOCIN POLYETHER ANALOGUES AS METAL CHELATION AGENTS | FerroKin BioScience, Inc. (US) | 2013-02-28 | — | — | US | disclosed |
| US-20130053387-A1 | DESAZADESFERROTHIOCIN AND DESAZADESFERROTHIOCIN POLYETHER ANALOGUES AS METAL CHELATION AGENTS | FerroKin BioScience, Inc. (US) | 2013-02-28 | — | — | US | disclosed |
| WO-2011140232-A2 | DESAZADESFERROTHIOCIN AND DESAZADESFERROTHIOCIN POLYETHER ANALOGUES AS METAL CHELATION AGENTS | FERROKIN BIOSCIENCES, INC (US) | 2011-11-10 | — | — | WO | disclosed |
| US-20110275636-A1 | DESAZADESFERROTHIOCIN AND DESAZADESFERROTHIOCIN POLYETHER ANALOGUES AS METAL CHELATION AGENTS | FERROKIN BIOSCIENCES, INC. (US) | 2011-11-10 | — | — | US | disclosed |
| WO-2011140232-A2 | DESAZADESFERROTHIOCIN AND DESAZADESFERROTHIOCIN POLYETHER ANALOGUES AS METAL CHELATION AGENTS | FERROKIN BIOSCIENCES, INC (US) | 2011-11-10 | — | — | WO | disclosed |
| US-20110275636-A1 | DESAZADESFERROTHIOCIN AND DESAZADESFERROTHIOCIN POLYETHER ANALOGUES AS METAL CHELATION AGENTS | FERROKIN BIOSCIENCES, INC. (US) | 2011-11-10 | — | — | US | disclosed |
| US-20110275636-A1 | DESAZADESFERROTHIOCIN AND DESAZADESFERROTHIOCIN POLYETHER ANALOGUES AS METAL CHELATION AGENTS | FERROKIN BIOSCIENCES, INC. (US) | 2011-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275636-A1 | DESAZADESFERROTHIOCIN AND DESAZADESFERROTHIOCIN POLYETHER ANALOGUES AS METAL CHELATION AGENTS | SLC39A14, SLC40A1, FTH1 | AR 4138/4885MAOB 3310/4885MAOA 3108/4885 |
| US-20250197388-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE | SI, VIP, APC | AR 4503/4885MAOB 1165/4885MAOA 2536/4885 |
| US-20130053387-A1 | DESAZADESFERROTHIOCIN AND DESAZADESFERROTHIOCIN POLYETHER ANALOGUES AS METAL CHELATION AGENTS | SLC39A14, SLC40A1, FTH1 | AR 4138/4885MAOB 3310/4885MAOA 3108/4885 |
| US-20150259306-A1 | DESAZADESFERROTHIOCIN ANALOGUES AS METAL CHELATION AGENTS | SLC40A1, SLC39A14, HAMP | AR 4240/4885MAOB 2768/4885MAOA 2621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.